PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-42.82%
Negative 5Y CAGR while VMC stands at 38.08%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-37.78%
Negative 3Y CAGR while VMC stands at 20.13%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
23.98%
5Y OCF/share CAGR at 50-75% of VMC's 32.67%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
38.24%
3Y OCF/share CAGR above 1.5x VMC's 19.20%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
No Data
No Data available this quarter, please select a different quarter.
-43.73%
Negative 5Y net income/share CAGR while VMC is 29.78%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-73.18%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
60.27%
5Y equity/share CAGR above 1.5x VMC's 36.31%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
46.82%
3Y equity/share CAGR above 1.5x VMC's 21.21%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
25.69%
Below 50% of VMC's 240.32%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
85.06%
3Y dividend/share CAGR above 1.5x VMC's 36.13%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.